Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price was down 3% during trading on Monday . The stock traded as low as $51.68 and last traded at $51.68. Approximately 411 shares traded hands during mid-day trading, a decline of 44% from the average daily volume of 734 shares. The stock had previously closed at $53.26.
Hikma Pharmaceuticals Stock Down 3.0%
The firm has a fifty day moving average of $55.31 and a 200 day moving average of $54.24.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Read More
- Five stocks we like better than Hikma Pharmaceuticals
- 3 REITs to Buy and Hold for the Long Term
- Analysts Make a Quantum Bet on D-Wave’s Cryogenic Packaging
- The How And Why of Investing in Oil Stocks
- Traders Turn Bullish on Housing Stocks Again—3 Leading the Way
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Onsemi’s August Pullback Is a Signal to Buy for Tech Investors
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
